ARRIVE: An AIDS Education/Relapse Prevention Model for High-Risk Parolees

References

• Anda R. F., Perlman S. B., D'Alessio D. J., Davis J. P., Dodson V. N. Hepatitis B in Wisconsin male prisoners: Considerations for serologic screening and vaccination. Am. J. Public Health 1985; 75: 1182–1185
   PubMed Web of Science ®Google Scholar
• Bird A. G., Gore S. M., Jolliffe D. W., Burns S. M. Anonymous HIV surveillance in Saughton Prison, Edinburgh. AIDS 1992; 6: 725–733
   PubMed Web of Science ®Google Scholar
• Bohlin A., Anzen B., Arneborn M., et al. HIV infection in pregnant women and perinatal transmission in Sweden. In Abstracts of the 5th International Conference on AIDS, Montreal, Canada. Available from International Development Research Center, OttawaCanada 1989
   Google Scholar
• Botvin G. J., Baker E., Renick N. L., Filazzola A. D., Botvin E. M. A cognitive-behavioral approach to substance abuse prevention. Addict. Behav. 1984; 9: 137–147
   PubMed Web of Science ®Google Scholar
• Buning E. C, Van Brussel G. H. A., Van Santen G. The “methadone by bus” project in Amsterdam. Br. J. Addict. 1990; 85: 1247–1250
   PubMedGoogle Scholar
• BUREAU OF JUSTICE STATISTICS. National Update: January 1992. Washington, DC 1992
   Google Scholar
• CENTERS FOR DISEASE CONTROL. HIV/AIDS Surveillance: December 1991. National AIDS Information Clearinghouse, Rockville, Maryland 1991
   Google Scholar
• Decker M. D., Vaugh W. K., Brodie J. S., Hutcheson R. H., Schaffner W. Seroepidemiology of Hepatitis B in Tennessee prisoners. J. Infect. Dis. 1984; 150: 450–459
   PubMed Web of Science ®Google Scholar
• Therapeutic Communities for Addictions, G. De Leon, J. T. Ziegenfuss. Charles C. Thomas, Springfield, Illinois 1986
   Google Scholar
• Des Jarlais D. C, Friedman S. R. HIV infection among intravenous drug users: Epidemiology and risk reduction. AIDS 1987; 1: 67–76
   PubMed Web of Science ®Google Scholar
• Sourcebook of Criminal Justice Statistics: 1985, T. J. Flanagan, E. F. McGarrell. United States Department of Justice, Bureau of Justice Statistics, Washington, DC 1986
   Google Scholar
• Gartner A., Riessman F. Self-Help in the Human Services. Jossey-Bass, San Francisco 1977
   Google Scholar
• Ginzburg H. M., French J., Jackson J., Hartsock P. I., Macdonald M. G., Weiss S. H. Health education and knowledge assessment of HTLV-III diseases among intravenous drug users. Health Educ. Q. 1986; 13: 373–382
   PubMedGoogle Scholar
• Glass G. E., Hausler W. J., Loeffelholz P. L., Yesalis C. E. Seroprevalence of HIV antibody among individuals entering the Iowa prison system. Am. J. Public Health 1988; 78: 447–449
   PubMed Web of Science ®Google Scholar
• Hammett T. R., Moini S. 1990 Update on AIDS in Prisons and Jails. National Institute of Justice, Washington, DC 1991
   Google Scholar
• Hoxie N. J., Vergeront J. M., Frisby H. R., Pfister J. R., Golubjatnkov R., Davis J. P. HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin. Am. J. Public Health 1990; 80: 1129–1131
   PubMed Web of Science ®Google Scholar
• Hubbard R. L., Marsden M. E., Rachal J. V., Harwood H. J., Cavanaugh E. R., Ginzburg H. M. Drug Abuse Treatment: A National Study of Effectiveness. University of North Carolina Press, Chapel Hill, North Carolina 1989
   Google Scholar
• Hull H. F., Lyons L. H., Mann J. M., Hadler S. C, Steece R., Skeels M. R. Incidence of Hepatitis B in the penitentiary of New Mexico. Am. J. Public Health 1985; 175: 1213–1214
   Google Scholar
• Hunt D. E. AIDS in Probation and Parole. National Institute of Justice, Washington, DC 1989
   Google Scholar
• Innes C. A. Profile of State Inmates: Bureau of Justice Statistics Special Report. U.S. Department of Justice, Washington, DC 1988
   Google Scholar
• Kall K. I., Olin R. G. HIV status and changes in risk behavior among intravenous drug users in Stockholm 1987–1988. AIDS 1990; 4: 153–157
   PubMed Web of Science ®Google Scholar
• Lange W. R., Snyder F. R., Lozovsky D., Kaistha V., Kaczaniuk M. A., Jaffe J. H. Geographic distribution of human immunodeficiency virus markers in parenteral drug abusers. Am. J. Public Health 1988; 78: 443–446
   PubMed Web of Science ®Google Scholar
• Leukefeld C. G., Tims F. M. Compulsory treatment: A review of findings. Compulsory Treatment of Drug Abuse: Research and Clinical Practice, C. G. Leukefeld, F. M. Tims. National Institute on Drug Abuse, Washington, DC 1988, NIDA Research Monograph 86
   Google Scholar
• Lorenco R., Minkovis R., Schechtmann M., Piovezano M., Ayrosa Galvao P., BadarÓ R., Johnson W. D., JR. Prospective Study of the Epidemiology of HIV-1 Infection in Male Prison Inmates in Sáo Paulo, Brazil. Presented at the VIII International Conference on AIDS. AmsterdamThe Netherlands June, 1992
   Google Scholar
• Magura S., Grossman J. I., Lipton D. S. Determinants of needle-sharing among intravenous drug users. Am. J. Public Health 1989; 79: 459–462
   PubMed Web of Science ®Google Scholar
• Magura S., Rosenblum A. R., Joseph H. AIDS risk among intravenous drug-using offenders. Crime Delinq. 1991a; 37: 86–100
   Web of Science ®Google Scholar
• Magura S., Shapiro J., Siddiqi Q., Lipton D. S. Variables influencing condom use among IV drug users. Am. J. Public Health 1990; 80: 82–84
   PubMed Web of Science ®Google Scholar
• Magura S., Siddiqi Q., Shapiro J., Grossman J. I., Lipton D. S., Marion I. J., Weisenfield L., Amann K. R., Koger J. Outcomes of a comprehensive AIDS prevention program for methadone patients. Int. J. Addict. 1991b; 26: 629–655
   PubMed Web of Science ®Google Scholar
• Marmor M., Des Jarlais D. C, Cohen H., Friedman S. R., Beatrice S. T., Dubin N., El-Sadr W., Mildvan D., Yancovitz S., Mathur U., Holzman R. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1987; 1: 39–44
   PubMed Web of Science ®Google Scholar
• Mayers M., Davenny K., Schoenbaum E., et al. Long-term follow-up of infants born to intravenous drug users of known HIV serostatus in the Bronx, NY. In Abstracts of the 5th International Conference on AIDS. Montreal, Canada. Available from International Development Research Center, OttawaCanada 1989; 315
   Google Scholar
• McBride D. C, Inciardi J. A. AIDS and the IV drug users in the criminal justice system. J. Drug Issues 1990; 20: 267–280
   Web of Science ®Google Scholar
• NATIONAL INSTITUTE OF JUSTICE. DUF: 1988 Drug Use Forecasting Annual Report. Washington, DC 1990
   Google Scholar
• NATIONAL INSTITUTE ON DRUG ABUSE; NIDA outreach demonstration projects provide insight into AIDS risk behaviors. NIDA Notes 1989; 4: 1–9
   Google Scholar
• NEW YORK STATE DEPARTMENT OF HEALTH. AIDS in New York State. Albany, New York 1989
   Google Scholar
• NEW YORK STATE DEPARTMENT OF HEALTH. AIDS Surveillance Quarterly Updata for Cases Reported through September 1991. Albany, New York 1991
   Google Scholar
• Vlahov D., Brewer T. F., Castro K. G., Narkunas J. P., Salive M. E., Ullrich J., Munoz A. Prevalence of antibody to HIV-1 among entrants to US correctional facilities. JAMA 1991; 265: 1129–1132
   PubMed Web of Science ®Google Scholar
• Vlahov D., Munoz A., Brewer F., Taylor E., Canner C, Polk B. F. Seasonal and annual variation of antibody to HIV-1 among inmates entering Maryland prisons: Update. AIDS 1990; 4: 345–350
   PubMed Web of Science ®Google Scholar
• Wexler H. K., Falkin G. P., Lipton D. S. Outcome evaluation of a prison therapeutic community for substance abuse treatment. Crim. Justice Behav. 1990; 17: 71–92
   Web of Science ®Google Scholar
• Wexler H. K., Josepher H., Josepher M. S. Project ARRIVE Training Manual. Final Report to the National Institute on Drug Abuse. National Development and Research Insititutes, Inc, New York 1991
   Google Scholar